Suppr超能文献

Calcium dysregulation in Alzheimer's disease: unraveling the molecular nexus of neuronal dysfunction and therapeutic opportunities.

作者信息

Chaudhary Bharat, Kumari Sneha, Dhapola Rishika, Sharma Prajjwal, Paidlewar Mohit, Vellingiri Balachandar, Medhi Bikash, HariKrishnaReddy Dibbanti

机构信息

Advanced Pharmacology and Neuroscience Laboratory, Department of Pharmacology, School of Health Sciences, Central University of Punjab, Ghudda, Bathinda 151 401 Punjab, India.

Human Cytogenetics and Stem Cell Laboratory, Department of Zoology, School of Basic Sciences, Central University of Punjab 151401 Bathinda, Punjab, India.

出版信息

Biochem Pharmacol. 2025 Aug 5;242(Pt 2):117211. doi: 10.1016/j.bcp.2025.117211.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by Aβ accumulation and tau hyperphosphorylation. Calcium dysregulation also plays a key role in its progression. As a vital second messenger, calcium ions regulate neuronal communication, memory formation, and learning, particularly in the hippocampus. Their levels are influenced by excitatory signaling, synapse formation, and neurotransmitter release. In AD, Ca dyshomeostasis occurs near amyloid plaques, marked by elevated intracellular calcium in neurons, microglia, and astrocytes, along with increased neuronal activity. Calcium dyshomeostasis promotes neurofibrillary tangle formation and amyloid-beta deposition through various molecular and signaling pathways. Elevated intracellular calcium accumulation results in multiple pathologies associated with AD, such as neuroinflammation, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, apoptosis, and excitotoxicity through various calcium signaling pathways such as calcineurin (CAN), calcium homeostasis modulator 2 (CALHM2), Mitogen-Activated Protein Kinase, Extracellular Signal-Regulated Kinase/ cAMP Response Element-Binding Protein (MAP/ERK/CREB), Wnt/β-catenin, Transient Receptor Potential Melastatin 2 (TRPM2), and Nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3 (NLRP3) pathway. It is crucial to find the gap between calcium increase overloads and those associated with the neuropathology of AD. Several drugs target calcium signaling pathways and inhibit the disease progression in preclinical and clinical studies. The article highlights the significance of using therapeutic approaches specifically targeting calcium signalling pathways to enhance cognitive performance and decrease the progression of AD. Targeting calcium signalling holds promise for addressing the multifaceted pathologies of AD that will aid in combating the disease.

摘要

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验